Cantor Fitzgerald Investment Advisors L.P. Raises Holdings in CVS Health Co. (NYSE:CVS)

Cantor Fitzgerald Investment Advisors L.P. lifted its position in CVS Health Co. (NYSE:CVS) by 6.0% in the 4th quarter, HoldingsChannel.com reports. The fund owned 404,443 shares of the pharmacy operator’s stock after buying an additional 22,926 shares during the period. CVS Health accounts for 1.3% of Cantor Fitzgerald Investment Advisors L.P.’s portfolio, making the stock its 22nd biggest position. Cantor Fitzgerald Investment Advisors L.P.’s holdings in CVS Health were worth $18,155,000 as of its most recent SEC filing.

A number of other hedge funds also recently added to or reduced their stakes in CVS. MidAtlantic Capital Management Inc. bought a new position in shares of CVS Health in the 3rd quarter worth $25,000. Ridgewood Investments LLC lifted its position in shares of CVS Health by 255.7% during the fourth quarter. Ridgewood Investments LLC now owns 626 shares of the pharmacy operator’s stock valued at $28,000 after buying an additional 450 shares during the last quarter. Livelsberger Financial Advisory bought a new stake in shares of CVS Health in the 3rd quarter valued at about $31,000. Legacy Investment Solutions LLC bought a new position in shares of CVS Health during the 3rd quarter worth approximately $31,000. Finally, Reston Wealth Management LLC purchased a new stake in CVS Health during the third quarter valued at approximately $32,000. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. Royal Bank of Canada reduced their price target on CVS Health from $68.00 to $58.00 and set an “outperform” rating on the stock in a research report on Friday, November 15th. Deutsche Bank Aktiengesellschaft upgraded CVS Health from a “hold” rating to a “buy” rating and set a $66.00 price target for the company in a research note on Tuesday, December 3rd. Wells Fargo & Company upgraded CVS Health from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. Edward Jones upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research note on Thursday, January 30th. Finally, UBS Group raised their price target on shares of CVS Health from $60.00 to $62.00 and gave the stock a “neutral” rating in a report on Thursday, November 7th. One research analyst has rated the stock with a sell rating, six have issued a hold rating and fourteen have issued a buy rating to the stock. According to data from MarketBeat.com, CVS Health has a consensus rating of “Moderate Buy” and a consensus target price of $68.12.

CVS Health Price Performance

CVS Health stock opened at $53.95 on Friday. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.59 and a current ratio of 0.80. The company’s fifty day moving average price is $50.90 and its 200 day moving average price is $56.02. The stock has a market capitalization of $67.90 billion, a P/E ratio of 13.69, a P/E/G ratio of 0.60 and a beta of 0.61. CVS Health Co. has a 1 year low of $43.56 and a 1 year high of $80.75.

CVS Health (NYSE:CVS) last announced its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter last year, the firm posted $2.21 EPS. The firm’s revenue for the quarter was up 6.3% on a year-over-year basis. As a group, equities research analysts anticipate that CVS Health Co. will post 5.14 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd were issued a $0.665 dividend. The ex-dividend date was Thursday, January 23rd. This represents a $2.66 dividend on an annualized basis and a yield of 4.93%. CVS Health’s payout ratio is 67.51%.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.